The National Biologics Facility (NBF) provides key infrastructure maintained under phase-appropriate quality systems to support therapeutic discovery, from screening of antibody libraries and production of high-quality recombinant proteins as small-molecule drug targets, through to novel, engineered biologics, vaccine antigens and diagnostic reagents.
NBF is a network of facilities, platform technologies and subject matter experts focused on the development of your biotherapeutic from discovery through to the scale-up and manufacturing of clinically-relevant material.

Biologics & Vaccines
Available expertise
Transient and Stable Expression
NBF has extensive experience across all nodes producing a wide range of proteins in different expressions systems.